These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29532156)

  • 21. [Adrenergic regulation of potassium homeostasis].
    Martín C; González Buitrago JM; Laso FJ
    Med Clin (Barc); 1991 Mar; 96(11):424-7. PubMed ID: 1675314
    [No Abstract]   [Full Text] [Related]  

  • 22. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy.
    Muzzarelli S; Maeder MT; Toggweiler S; Rickli H; Nietlispach F; Julius B; Burkard T; Pfisterer ME; Brunner-La Rocca HP;
    Am J Cardiol; 2012 Mar; 109(5):693-8. PubMed ID: 22152974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.
    Talatinian A; Chow SL; Heywood JT
    Pharmacotherapy; 2012 Sep; 32(9):827-37. PubMed ID: 22949142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperkalemia, heart failure and reduced renal function].
    Bugge JF
    Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1354-5. PubMed ID: 20596118
    [No Abstract]   [Full Text] [Related]  

  • 25. What is the risk of hyperkalaemia in heart failure?
    Bielecka-Dabrowa A; Rysz J; Mikhailidis DP; Banach M
    Expert Opin Pharmacother; 2011 Oct; 12(15):2329-38. PubMed ID: 21770818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spironolactone in chronic hemodialysis patients improves cardiac function.
    Taheri S; Mortazavi M; Shahidi S; Pourmoghadas A; Garakyaraghi M; Seirafian S; Eshaghian A; Ghassami M
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):392-7. PubMed ID: 19414940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta blockers and heart failure].
    D'Amore F; Santoro AM; Schirripa R
    Clin Ter; 1997 Nov; 148(11):531-5. PubMed ID: 9494255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-blockers treatment in heart failure with atrial fibrillation--Who should we believe?
    Chen Y; Huang W; Huang Y; Hu Y
    Int J Cardiol; 2016 Jan; 203():60-1. PubMed ID: 26492311
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of heart failure with spironolactone--trial and tribulations.
    McMurray JJ; O'Meara E
    N Engl J Med; 2004 Aug; 351(6):526-8. PubMed ID: 15295043
    [No Abstract]   [Full Text] [Related]  

  • 30. The dysfunction of ammonia in heart failure increases with an increase in the intensity of resistance exercise, even with the use of appropriate drug therapy.
    Medeiros WM; Carvalho AC; Peres P; De Luca FA; Gun C
    Eur J Prev Cardiol; 2014 Feb; 21(2):135-44. PubMed ID: 22952290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facility variation and predictors of serum potassium monitoring after initiation of a mineralocorticoid receptor antagonist in patients with heart failure.
    Chauhan V; Dev S; Pham M; Lin S; Heidenreich P
    Am Heart J; 2015 Sep; 170(3):543-9. PubMed ID: 26385038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of partusisten in prevention of hyperkalemia in patients with chronic glomerulonephritis with initial forms of renal failure].
    Skinskiĭ IM; Komandenko MS; Shulutko BI; Zamoskovskaia GA
    Klin Med (Mosk); 1991 Oct; 69(10):83-4. PubMed ID: 1766229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes.
    Takahama H; Yokoyama H; Kada A; Sekiguchi K; Fujino M; Funada A; Amaki M; Hasegawa T; Asakura M; Kanzaki H; Anzai T; Kitakaze M
    J Cardiol; 2013 Jan; 61(1):58-64. PubMed ID: 23165149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperkalemia: therapeutic options in acute and chronic renal failure.
    Kemper MJ; Harps E; Müller-Wiefel DE
    Clin Nephrol; 1996 Jul; 46(1):67-9. PubMed ID: 8832156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperkalaemia in heart failure: binding the patient to improved treatment?
    Konstam MA
    Eur J Heart Fail; 2015 Oct; 17(10):997-9. PubMed ID: 26443125
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of potassium excess on diuresis in congestive heart failure].
    ENGELL ES; BERKMEN R
    Turk Tip Cemiy Mecm; 1955 Jun; 21(6):256-63. PubMed ID: 13274573
    [No Abstract]   [Full Text] [Related]  

  • 37. Nonselective Beta-adrenergic blockade augments fasting hyperkalemia in hemodialysis patients.
    Nowicki M; Miszczak-Kuban J
    Nephron; 2002 Jun; 91(2):222-7. PubMed ID: 12053057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension.
    Kovesdy CP; Appel LJ; Grams ME; Gutekunst L; McCullough PA; Palmer BF; Pitt B; Sica DA; Townsend RR
    J Am Soc Hypertens; 2017 Dec; 11(12):783-800. PubMed ID: 29030153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the alpha-1-adrenergic receptor blocker doxazosin on exercise-induced hyperkalemia in hemodialysis patients.
    Nowicki M; Waluś T; Kokot F
    Kidney Blood Press Res; 2002; 25(1):55-60. PubMed ID: 11834878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J; Bułło B; Rutkowski B
    Przegl Lek; 2005; 62(7):732-3. PubMed ID: 16463712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.